Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MDxHealth (MDXH) Shares Outstanding (Weighted Average) (2021 - 2025)

Historic Shares Outstanding (Weighted Average) for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to $60000.0.

  • MDxHealth's Shares Outstanding (Weighted Average) rose 50000.0% to $60000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $60000.0, marking a year-over-year increase of 50000.0%. This contributed to the annual value of $34.7 million for FY2024, which is 7224753.12% up from last year.
  • Latest data reveals that MDxHealth reported Shares Outstanding (Weighted Average) of $60000.0 as of Q3 2025, which was up 50000.0% from $1.9 billion recorded in Q2 2025.
  • Over the past 5 years, MDxHealth's Shares Outstanding (Weighted Average) peaked at $1.9 billion during Q2 2025, and registered a low of $5000.0 during Q1 2022.
  • Over the past 5 years, MDxHealth's median Shares Outstanding (Weighted Average) value was $48000.0 (recorded in 2023), while the average stood at $168.8 million.
  • In the last 5 years, MDxHealth's Shares Outstanding (Weighted Average) tumbled by 9998.68% in 2022 and then skyrocketed by 7224753.12% in 2024.
  • Quarter analysis of 5 years shows MDxHealth's Shares Outstanding (Weighted Average) stood at $128.8 million in 2021, then plummeted by 99.99% to $17000.0 in 2022, then skyrocketed by 182.35% to $48000.0 in 2023, then skyrocketed by 72247.53% to $34.7 million in 2024, then plummeted by 99.83% to $60000.0 in 2025.
  • Its last three reported values are $60000.0 in Q3 2025, $1.9 billion for Q2 2025, and $39000.0 during Q1 2025.